Sector Chart FUSN PHAR

Equities

Market Closed - Nasdaq Other stock markets 01:30:04 17/05/2024 am IST			5-day change	1st Jan Change
21.46 ^USD	-0.37%		+0.37%	+123.31%

09/05	Fusion Pharmaceuticals Inc. Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer	CI
07/05	Fusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

	Capi.	Sales growth	Profitability	Finances	EV / Sales	P/E ratio